[Mechanism and frequency of hemorrhagic complications in patients with plasma cell myeloma (author's transl)].
D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000097:blood; D001779:Blood Coagulation Factors; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000097:blood; D008558:Melphalan / Q000494:pharmacology / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy; D010265:Paraproteinemias / Q000097:blood; D010958:Plasminogen; D010960:Plasminogen Activators
D001779:Blood Coagulation Factors; D010958:Plasminogen; D010960:Plasminogen Activators; D008558:Melphalan
Mechanizmy i czestość powikłań krwotocznych u chorych z siatkowiakiem plazmocytowym.